ALS patients get expanded access to experimental Sugar-Based drug
Disease control
NO_LONGER_AVAILABLE
This program gives ALS patients who cannot join other clinical trials access to an experimental drug called trehalose (SLS-005). Trehalose is a sugar solution given once a week through a vein. The goal is to see if it can help control the disease. The program is no longer availab…
Sponsor: Seelos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC